EASE MITRAL Expertise-based Assessment Study on Clinical Efficacy of Profile 3D in MITRAL Valve Annuloplasty

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2015 by Medtronic Bakken Research Center
Sponsor:
Information provided by (Responsible Party):
Medtronic Bakken Research Center
ClinicalTrials.gov Identifier:
NCT01112566
First received: April 27, 2010
Last updated: May 8, 2015
Last verified: May 2015

April 27, 2010
May 8, 2015
February 2013
October 2015   (final data collection date for primary outcome measure)
  • Identify the patient population for which a Profile 3D Annuloplasty Ring is chosen to repair the mitral valve insufficiency. [ Designated as safety issue: No ]
  • Assess the percentage of patients that are chronically relieved from mitral valve dysfunction [ Time Frame: 6-12 months follow up ] [ Designated as safety issue: No ]
  • Determine the level of mitral valve regurgitation in patients [ Time Frame: 6-12 months post-surgery ] [ Designated as safety issue: No ]
  • Reduction of insufficiency of the repaired mitral valve, both in terms of classification of dysfunction and level of regurgitation. [ Time Frame: Within 3 months prior to implantation and at 9 month follow-up ] [ Designated as safety issue: No ]
  • Leaflet coaptation [ Time Frame: Within 3 months prior to implantation and at 9 month follow-up ] [ Designated as safety issue: No ]
  • Identification of the patient population for which a Profile 3D annuloplasty ring is used for the surgical repair of a regurgitant mitral valve. [ Time Frame: Within 3 months prior to implantation ] [ Designated as safety issue: No ]
Complete list of historical versions of study NCT01112566 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
EASE MITRAL Expertise-based Assessment Study on Clinical Efficacy of Profile 3D in MITRAL Valve Annuloplasty
EASE MITRAL Expertise-based Assessment Study on Clinical Efficacy of Profile 3D in MITRAL Valve Annuloplasty

The goal of the study is to identify the patients suffering from a mitral valve condition who benefit from the implantation of a Profile 3D annuloplasty ring in terms of acute and long-term relief of mitral valve regurgitation.

Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

The patient population includes all patients suffering from mitral valve disease, indicated for a mitral valve repair procedure, either as a stand-alone procedure or concomitant to a coronary artery bypass grafting, an aortic replacement or tricuspid valve repair and/or the treatment of atrial fibrillation, and for which the surgeon considers the implantation of a Profile 3D annuloplasty product most appropriate to reconstruct the regurgitant valve.

Mitral Valve Insufficiency
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
150
October 2015
October 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Indicated for a surgical repair for moderate to severe mitral valve regurgitation at rest (level 2 or higher);
  • Willing to return to the hospital where the implantation originally occurred as part of the standard practice of care

Exclusion Criteria:

  • Heavily calcified valves
  • Valvular retraction with severely reduced mobility
  • Active bacterial endocarditis
  • Already participating in another investigational device study, possibly leading to bias and jeopardizing the scientific appropriate assessment of the study endpoints;
  • Life expectancy of less than one year;
  • Pregnant or desire to be pregnant within 12 months of the study treatment;
  • Under 18 years or over 85 years of age.
Both
18 Years to 85 Years
No
Contact: Marieke Gerards +31 43 356 6594 marieke.gerards@medtronic.com
Contact: Patrick Simons +31 43 356 6794 patrick.simons@medtronic.com
Canada,   Czech Republic,   France,   Germany,   Italy,   Saudi Arabia
Belgium,   United Kingdom
 
NCT01112566
BRC-CS-2010-03
No
Medtronic Bakken Research Center
Medtronic Bakken Research Center
Not Provided
Not Provided
Medtronic Bakken Research Center
May 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP